Webinar :Register now for webinar on 'Trade BankNifty in just 15 minutes a day' - By Asmita Patel
you are here: HomeNewsIndia

Loan recasts to only defer problem, NPAs may zoom up to 14% due to COVID-19: S&P Global Ratings

The agency also said operational outages and the recession because of the pandemic will have a deeper and longer impact on lenders than previously assumed, and estimated the gross non-performing assets ratio to rise up to 14 percent in FY21 from the 8.5 percent in FY20.
Jun 30, 2020 / 06:00 PM IST
File image
File image

Amid reports of the RBI mulling restructuring of loans, global rating agency S&P on Tuesday said that a loan recast will only defer NPAs recognition and not solve the problem.

The agency also said operational outages and the recession because of the pandemic will have a deeper and longer impact on lenders than previously assumed, and estimated the gross non-performing assets ratio to rise up to 14 percent in FY21 from the 8.5 percent in FY20.

"The COVID-19 pandemic may set back the recovery of India's banking sector by years, which could hit credit flows and, ultimately, the economy," the agency said.

The coronavirus pandemic has led to prolonged lockdowns and a chilling of economic activity, forcing the RBI to declare a six-month voluntary moratorium on loan repayments till September.

The RBI, which had stopped the practice of loan forbearance, is reportedly mulling to reintroduce restructuring with a few safeguards.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

"... restructuring may not resolve the problem. It may just defer NPL (non performing loans) recognition, as it did a few years ago,” the agency said.

It reminded that in the past, rampant restructuring had led the RBI to come up with an asset quality review and withdrew forbearance on the majority of restructured loans, leading to exceptionally high credit costs on banks.

In its base case, the agency expects slippages or the addition to the NPAs to come at 6 percent during the fiscal. If the RBI allows for restructuring of loans, it may reduce the loan slippages this fiscal, it noted.

Loan recoveries will be set back by “years” because of the COVID-19 pandemic, which will lead to a spike in the industry's non-performing assets (NPAs) ratio, it said.

The NPAs of the Indian banks will shoot-up to 13-14 percent at the end of FY21, up from the 8.5 percent in FY20, Standard & Poor's credit analyst Deepali Seth-Chhabria said.

Resolution of stressed or bad-debt situations will likely unfold slowly, which will leave banks saddled with a huge stock of bad loans next year as well, the agency said, estimating an improvement of only 1 percentage point in the NPA ratio in FY22.

According to its credit analyst Geeta Chugh, non-bank finance companies (NBFCs) will be more hit as compared to banks because of lending to weaker sections, reliance on wholesale funding, and liquidity difficulties because of a higher proportion of borrowers opting for default.

The agency said the NPAs have been reducing over the past 18 months, after hitting a peak of 11.6 percent in March 2018, when the RBI had undertaken an exhaustive asset quality review leading to emergence of high amounts of hidden stress coming out. "Businesses' operational outages and the recession will have a deeper and longer effect on lenders than we previously assumed," it said.

From a sectoral perspective, it said airlines, hotels, malls, multiplexes, restaurants, and retail may see a significant loss of revenue and profits due to the outbreak, while highly leveraged sectors like real estate developers, telecom companies and power firms may remain a source of increased bad debt, it said.

Micro, small and medium enterprises will be the most vulnerable, but the government's loan guarantee scheme will be of help to them, it said, adding there can be more bad loans from the retail sector especially in the unsecured loans segment.

As the overall confidence dips, credit growth will be “anemic” and will be in the low single digits for FY21, it said.

The state-run banks need up to Rs 40,000 crore in capital support from the government during the current fiscal, which is higher than what it has pumped in the past, the rating agency said.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Jun 30, 2020 06:00 pm

stay updated

Get Daily News on your Browser
Sections